[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-001", "question": "A 45-year-old man with a history of alcoholic cirrhosis presents to the ICU with massive upper gastrointestinal bleeding. Despite endoscopic intervention and octreotide infusion, bleeding persists, and he develops hemodynamic instability. Transjugular intrahepatic portosystemic shunt (TIPS) is considered, but imaging reveals a rare anatomical variant. What is the most appropriate next step in management?", "options": ["Proceed with TIPS using a covered stent to mitigate risks", "Initiate balloon tamponade with a Sengstaken-Blakemore tube", "Administer terlipressin as an alternative vasoconstrictor", "Perform urgent surgical portocaval shunt", "Refer for angiographic embolization of the coronary vein"], "answer": "E", "answer_index": 4, "explanation": "In persistent variceal bleeding with anatomical variants precluding TIPS, angiographic embolization targets specific bleeding vessels like the coronary vein, offering a less invasive option. TIPS is contraindicated due to the variant, while surgical shunts carry high mortality in unstable patients. Terlipressin and balloon tamponade are temporizing but not definitive here.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "In this scenario, the patient has persistent variceal bleeding despite endoscopic and pharmacologic therapy, and TIPS is the standard rescue intervention.  \nHowever, imaging reveals a rare anatomical variant that likely makes TIPS technically difficult or contraindicated (e.g., portal vein thrombosis, abnormal vascular anatomy).  \nWhen TIPS is not feasible, balloon tamponade with a Sengstaken-Blakemore tube is a temporizing measure to stabilize the patient for definitive management, which could include other shunt procedures or emergent surgery if appropriate.  \nGiven the ongoing hemodynamic instability and failure of initial measures, balloon tamponade is the immediate next step to control bleeding while planning further intervention.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-002", "question": "A 62-year-old woman with metastatic breast cancer on paclitaxel develops acute dyspnea and hypoxemia. CT angiography shows no pulmonary embolism, but echocardiography reveals right ventricular strain. Bone marrow biopsy confirms tumor infiltration. What is the most likely diagnosis?", "options": ["Paclitaxel-induced pneumonitis", "Tumor microembolism syndrome", "Lymphangitic carcinomatosis", "Chemotherapy-associated pulmonary veno-occlusive disease", "Metastatic tumor thrombus in pulmonary arteries"], "answer": "B", "answer_index": 1, "explanation": "Tumor microembolism syndrome occurs when tumor cells embolize to pulmonary vasculature, causing right heart strain without macroscopic emboli, fitting this presentation in metastatic cancer. Lymphangitic carcinomatosis typically shows interstitial patterns on imaging, while paclitaxel pneumonitis is inflammatory. Veno-occlusive disease is more associated with stem cell transplant regimens.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has metastatic breast cancer on paclitaxel, acute dyspnea and hypoxemia, CT angiography negative for pulmonary embolism, but echocardiography shows right ventricular strain. Bone marrow biopsy shows tumor infiltration.  \n\nThis combination suggests **tumor microembolism syndrome** — tumor cells or aggregates embolize to small pulmonary arteries, causing increased pulmonary vascular resistance and right ventricular strain, but CT angiography is often negative because the emboli are too small to be seen.  \n\nPaclitaxel-induced pneumonitis would not typically cause RV strain without parenchymal findings explaining it. Lymphangitic carcinomatosis usually shows interstitial thickening on CT. Pulmonary veno-occlusive disease is rare and not directly linked to tumor infiltration of bone marrow. Metastatic tumor thrombus in large pulmonary arteries would likely be visible on CT angiography.  \n\nThe answer is B.  \n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-003", "question": "A 28-year-old man presents to the emergency department with severe headache, vomiting, and photophobia after a recent hiking trip. CSF analysis shows lymphocytic pleocytosis, elevated protein, and normal glucose. PCR for common viruses is negative, but serology reveals antibodies to a rare pathogen. What is the most appropriate initial management?", "options": ["Intravenous acyclovir for presumed herpes encephalitis", "Empiric antibiotics for bacterial meningitis", "Supportive care with close monitoring", "Corticosteroids to reduce inflammation", "Antifungal therapy targeting endemic mycoses"], "answer": "C", "answer_index": 2, "explanation": "This presentation suggests lymphocytic meningitis from a rare arbovirus like Jamestown Canyon virus, where supportive care is the mainstay as no specific antiviral exists. Acyclovir is for herpes, unnecessary here with negative PCR. Antibiotics are for bacterial etiologies, ruled out by CSF profile.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The presentation suggests lymphocytic meningitis with a travel history (hiking), negative viral PCR, and serology pointing to a rare pathogen.  \nGiven that a specific pathogen is suspected from serology, starting empiric antiviral or antibacterial therapy without confirmation is less appropriate.  \nFor many rare causes of viral or atypical meningitis (e.g., some arboviruses, rare zoonotic viruses), specific antiviral therapy often isn’t available, and management is mainly supportive while monitoring for complications.  \n\nThe single best initial approach is **supportive care with close monitoring** while awaiting further results and assessing for deterioration.\n\nThe answer is C"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-004", "question": "A 7-year-old boy with autism spectrum disorder presents with recurrent episodes of staring spells and facial twitching. EEG shows multifocal epileptiform discharges, and MRI reveals subtle cortical dysplasia. Genetic testing identifies a de novo mutation. What is the most effective first-line therapy?", "options": ["Valproic acid for broad-spectrum coverage", "Levetiracetam to minimize behavioral side effects", "Carbamazepine for focal seizures", "Vagus nerve stimulation as adjunct", "Ketogenic diet initiation"], "answer": "B", "answer_index": 1, "explanation": "In epileptic encephalopathy due to mutations like SCN8A, levetiracetam is preferred for its efficacy and lower risk of exacerbating behavioral issues in autism. Valproic acid can worsen aggression, while carbamazepine may aggravate generalized features. Dietary therapies are second-line.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has autism spectrum disorder with focal seizures (staring spells, facial twitching) and cortical dysplasia, suggesting a structural/metabolic epilepsy.  \nValproic acid is a broad-spectrum antiseizure medication effective in focal and generalized epilepsies and is often used in patients with developmental disorders and cortical malformations, especially when the epilepsy syndrome isn’t more specifically defined (e.g., as infantile spasms).  \nLevetiracetam can exacerbate behavioral issues in autism, carbamazepine may aggravate some generalized or multifocal discharges, and vagus nerve stimulation or ketogenic diet are not first-line.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-005", "question": "A 55-year-old man with Parkinson's disease develops sudden onset of dysarthria and hemiparesis. MRI shows acute infarction in the lenticulostriate territory, but vessel imaging is normal. Coagulation studies reveal an abnormality. What is the underlying mechanism?", "options": ["Cardioembolic stroke from atrial fibrillation", "Lacunar infarct due to small vessel disease", "Thrombotic stroke from antiphospholipid syndrome", "Vasculitis mimicking stroke", "Embolic stroke from levodopa-induced arrhythmia"], "answer": "C", "answer_index": 2, "explanation": "Antiphospholipid syndrome can cause thrombotic strokes in atypical territories without large vessel occlusion, especially with coagulation abnormalities. Lacunar infarcts are typically hypertensive, not matching this profile. Cardioembolism usually involves larger territories or arrhythmias, absent here.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has an acute lenticulostriate territory infarct (typical lacunar syndrome) with normal vessel imaging, suggesting a small deep infarct.  \nIn Parkinson’s disease, long-term levodopa use can cause hyperhomocysteinemia, which is a risk factor for small vessel disease and lacunar infarcts.  \nCoagulation studies revealing an abnormality (elevated homocysteine) would fit this mechanism, supporting lacunar infarct due to small vessel disease exacerbated by hyperhomocysteinemia.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-006", "question": "In the ICU, a 70-year-old patient with septic shock from pneumonia remains hypotensive despite vasopressors and fluids. Adrenal function testing shows a blunted cortisol response, but random cortisol is normal. What is the next step in management?", "options": ["Initiate hydrocortisone replacement therapy", "Add fludrocortisone for mineralocorticoid support", "Perform cosyntropin stimulation test", "Switch to alternative vasopressor like vasopressin", "Administer ascorbic acid and thiamine"], "answer": "D", "answer_index": 3, "explanation": "Relative adrenal insufficiency in sepsis may not respond to steroids if cortisol is normal; switching to vasopressin addresses vasoplegia more effectively. Hydrocortisone is controversial without clear deficiency. Cosyntropin is already implied by blunted response.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has septic shock with refractory hypotension despite vasopressors and fluids.  \nAdrenal function testing shows a blunted cortisol response (suggesting relative adrenal insufficiency), but random cortisol is normal.  \nIn septic shock, guidelines (e.g., Surviving Sepsis Campaign) suggest considering IV hydrocortisone if adequate fluid resuscitation and vasopressor therapy are insufficient to restore hemodynamic stability, especially if relative adrenal insufficiency is suspected.  \nThe cosyntropin stimulation test is a diagnostic test, but if clinical suspicion is high and the patient is unstable, treatment should not be delayed for further testing.  \n\nThe best next step in management is to start hydrocortisone.  \n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-007", "question": "A 38-year-old woman with chronic myeloid leukemia on dasatinib develops pleural effusions and fatigue. Cytogenetic analysis shows additional clonal evolution. What is the most appropriate therapeutic adjustment?", "options": ["Switch to imatinib to reduce pulmonary toxicity", "Add interferon-alpha for immunomodulation", "Initiate ponatinib for resistant mutations", "Dose reduce dasatinib and monitor", "Proceed to allogeneic stem cell transplant"], "answer": "C", "answer_index": 2, "explanation": "Clonal evolution in CML on dasatinib often indicates T315I mutation, for which ponatinib is effective despite pulmonary risks. Imatinib lacks potency against advanced disease. Transplant is considered but not first-line without failure of second-generation TKIs.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has chronic myeloid leukemia on dasatinib with new pleural effusions (a known side effect of dasatinib) and evidence of clonal evolution, which indicates disease progression or resistance.  \nClonal evolution in CML while on a tyrosine kinase inhibitor is a sign of treatment failure and often requires a change in therapy. Ponatinib is a third-generation TKI effective against many resistant mutations, including the T315I mutation, and is indicated in cases of clonal evolution or resistance to prior TKIs.  \n\nThe answer is C"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-008", "question": "A 35-year-old woman in the emergency department collapses after ingesting an unknown substance. She has bradycardia, hypotension, and miosis. Atropine provides partial response, but symptoms recur. What is the definitive antidote?", "options": ["Pralidoxime for organophosphate poisoning", "N-acetylcysteine for acetaminophen", "Flumazenil for benzodiazepine overdose", "Physostigmine for anticholinergic toxicity", "Hydroxocobalamin for cyanide"], "answer": "A", "answer_index": 0, "explanation": "This cholinergic toxidrome suggests organophosphate poisoning, where pralidoxime regenerates acetylcholinesterase after initial atropine. Atropine alone is insufficient for severe cases. Other antidotes target different mechanisms not fitting the presentation.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient presents with bradycardia, hypotension, and miosis — signs of cholinergic excess (muscarinic effects).  \nAtropine (an antimuscarinic) provides partial but temporary improvement, which is characteristic of organophosphate poisoning, where acetylcholinesterase is inhibited.  \nPralidoxime (2-PAM) works as a cholinesterase reactivator and is the definitive antidote to reverse the nicotinic effects and prevent “aging” of the enzyme.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-009", "question": "A 12-year-old girl with juvenile idiopathic arthritis on etanercept develops fever, rash, and lymphadenopathy. Serology is positive for a virus, but PCR on lymph node biopsy reveals clonal T-cell population. What is the most likely complication?", "options": ["Drug reaction with eosinophilia and systemic symptoms", "EBV-associated lymphoproliferative disorder", "Macrophage activation syndrome", "Secondary hemophagocytic lymphohistiocytosis", "TNF inhibitor-induced lymphoma"], "answer": "E", "answer_index": 4, "explanation": "TNF inhibitors like etanercept increase risk of T-cell lymphomas, especially with clonal populations on biopsy, beyond viral associations. EBV-LPD is B-cell predominant. MAS and HLH are cytokine-driven without clonality.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient is on etanercept (a TNF inhibitor), which increases the risk of EBV-associated lymphoproliferative disorders, especially in children.  \nFever, rash, lymphadenopathy, positive viral serology (likely EBV), and clonal T-cell population in lymph node biopsy point toward a lymphoproliferative disorder rather than a simple drug reaction or hemophagocytic syndrome.  \nWhile TNF inhibitors are associated with increased lymphoma risk, the presence of positive viral serology and clonal T-cell proliferation in this context is most consistent with EBV-driven lymphoproliferation.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-010", "question": "A 68-year-old man with amyotrophic lateral sclerosis presents with progressive dysphagia and aspiration. Videofluoroscopy shows pharyngeal weakness. Non-invasive ventilation is in use. What is the most appropriate intervention?", "options": ["Percutaneous endoscopic gastrostomy placement", "Botulinum toxin injection into cricopharyngeus", "Tracheostomy for airway protection", "Speech therapy with swallowing exercises", "Pharmacologic enhancement with edrophonium"], "answer": "B", "answer_index": 1, "explanation": "In ALS with cricopharyngeal dysfunction causing dysphagia, botulinum toxin relaxes the muscle to improve swallowing, a targeted approach before invasive feeding. PEG is for nutrition but not dysphagia mechanism. Tracheostomy addresses ventilation, not swallowing.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "In amyotrophic lateral sclerosis (ALS) with progressive dysphagia and aspiration, pharyngeal weakness is the primary issue.  \nNon-invasive ventilation is already in use, indicating respiratory involvement.  \nPercutaneous endoscopic gastrostomy (PEG) placement is recommended in ALS to maintain nutrition and reduce aspiration risk when dysphagia progresses, even before severe weight loss occurs.  \n\nOther options are less appropriate:  \n- Botulinum toxin injection is for cricopharyngeal dysfunction, not generalized pharyngeal weakness.  \n- Tracheostomy is not first-line for dysphagia alone in ALS.  \n- Speech therapy and exercises have limited benefit once aspiration is present in progressive neuromuscular disease.  \n- Edrophonium is for myasthenia gravis, not ALS.  \n\nThe answer is A"}]